The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Spain Edition

  • ID: 3942395
  • Report
  • Region: Spain
  • 50 pages
  • PatientView
1 of 4

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Boehringer Ingelheim
  • Gilead Sciences
  • Merck & Co (US)
  • Pfizer
  • MORE

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 108 patient groups based in Spain in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the Spanish pharma industry during 2015, as well as the performance of 14 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.

The report also offers, as case studies, survey responses from two companies, AbbVie Spain and Novartis Spain. These companies explain what they are doing on the subject of global patient centricity, and comment about their relationships with patient groups.

Profiles of the 14 Companies, According To the Spanish Patient Groups Familiar with These Companies, or Which Have Worked With Them 

Each profile contains

Company Background Information

  •  Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
  •  The profiled company’s main treatment subject areas (and areas of R&D).
  •  A mission statement from the profiled company.

How the Company Has Performed At Six Indicators of Corporate Reputation

  •  The profiled company’s performance at the six indicators of corporate reputation in 2015, according to the Spanish patient groups familiar with the company.
  •  The profiled company’s performance at the six indicators of corporate reputation, according to the Spanish patient groups that have worked with the company.
  •  How the profiled company performed among Spanish patient groups for different therapy areas, compared with the company’s global averages for Spanish patient groups in 2015.

How the Company Ranks For Corporate Reputation Compared With Other Companies

  •  The profiled company’s rankings among Spanish patient groups in 2015 for the six indicators of corporate reputation, compared with 13 other companies.
  •  The profiled company’s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies.

Profile of the Patient Groups Familiar with the Company

  • Other companies that partner with a significant number of the profiled company’s partner patient groups.
  • The countries of the patient groups familiar with the profiled company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Boehringer Ingelheim
  • Gilead Sciences
  • Merck & Co (US)
  • Pfizer
  • MORE

ABOUT THIS REPORT 

WHAT DID SPANISH PATIENT GROUPS SAY ABOUT PHARMA IN 2015?

  • Summary of the industry-wide findings (as judged by Spanish patient groups)

A FEW COMMENTS ON THE SPANISH CORPORATE RANKINGS 

WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION?

COMMENTS FROM SPANISH PATIENT GROUPS, 2015 

CASE STUDY: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT...

  •  AbbVie Spain
  •  Novartis Spain

METHODOLOGY OF THE PATIENT-GROUP SURVEY 

QUESTIONNAIRE FOR PHARMA COMPANIES 2015 

APPENDIX 1: Data on how Spanish patient groups see the pharmaceutical industry in 20
 
APPENDIX 2: Rankings of the 14 pharma companies for each of the 6 indicators of corporate reputation, as perceived by Spanish patient groups in 20

APPENDIX 3: Profiles of the 14 companies
 
APPENDIX 4: Profiles of the 108 respondent Spanish patient groups

LIST OF TABLES AND CHARTS—BASED ON THE VIEWS OF SPANISH PATIENT GROUPS, 2015
Percentage of Spanish patient groups claiming familiarity with the company 
Percentage of Spanish patient groups claiming familiarity with the company, and which also worked with it  
Percentage of patient groups worldwide (by geographic region) stating that the GENERIC pharma industry has an “Excellent” or “Good” corporate reputation, 20
Percentage of patient groups worldwide (by geographic region) stating that pharma is “Excellent” or “Good” at MAKING USEFUL PRODUCTS
Percentage of patient groups worldwide (by geographic region) stating that pharma is “Excellent” or “Good” at PROVIDING SERVICES TO PATIENTS OUTSIDE THE BUSINESS REMIT
Percentage of patient groups worldwide (by geographic region) stating that pharma is “Excellent” or “Good” at HAVING FAIR PRICING POLICIES
Final ranking of 14 pharma companies in Spain, 2015, according to Spanish patient groups (v. final ranking of 7 pharma companies in Spain, 2014)
If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015?
What do you think has happened to the corporate reputation of the pharma industry over the past five years? 
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
Companies with the most effective patient-centred strategy (rankings of 14 companies, 2015) 
Companies providing the best high-quality patient information (rankings of 14 companies, 2015) 
Companies with the best record on patient safety (rankings of 14 companies, 2015) 
Companies with the most-useful high-quality products (rankings of 14 companies, 2015) 
Companies with the best record of transparency (rankings of 14 companies, 2015) 
Companies with the best record on integrity (rankings of 14 companies, 2015) 
Rankings of the 14 pharmaceutical companies in 2015, ALPHABETIC ORDER
Rankings of the 14 pharmaceutical companies in 2015, HIGHEST TO LOWEST
Main specialisations of 2015’s 108 respondent Spanish patient groups
Geographic remit of 2015’s 108 respondent Spanish patient groups

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie
  • AstraZeneca
  • B-MS
  • Bayer
  • Boehringer Ingelheim
  • Eli Lilly
  • GSK Janssen
  • Gilead Sciences
  • Merck & Co (US)
  • Novartis
  • Pfizer
  • Roche
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll